Table 3 Gender examination of clinico-demographic factors for association with polypharmacy

Age (years)

< 0.001

1.075 (1.048–1.101)

0.013

1.053 (1.011–1.097)

School years*

0.288

0.879 (0.692–1.116)

0.803

0.954 (0.658–1.382)

Educational level*

0.012

0.635 (0.446–0.904)

0.402

0.809 (0.492–1.329)

Partnership*

0.082

1.852 (0.925–3.710)

0.524

1.399 (0.498–3.928)

Place of residence*

0.068

1.254 (0.983–1.599)

0.104

0.725 (0.493–1.068)

Number of children*

0.068

0.742 (0.539–1.022)

0.448

1.251 (0.702–2.229)

Number of siblings*

0.618

0.960 (0.819–1.126)

0.321

0.848 (0.612–1.175)

EDSS*

< 0.001

1.653 (1.336–2.045)

0.005

1.454 (1.117–1.893)

Disease duration (years)*

0.993

1.000 (0.965–1.036)

0.179

0.959 (0.902–1.019)

Comorbidities*

< 0.001

3.632 (1.885–6.996)

< 0.001

6.213 (2.266–17.037)

Patient care*

< 0.001

5.598 (2.857–10.970)

< 0.001

11.820 (4.099–34.083)